Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RNLXYRenalytix plc

OTC · CIK 0001811115
Filer category<br>Emerging growth company
Entity typeoperating
SIC8071 Services-Medical Laboratories
FY end0630
XBRL facts261

Identity from submissions API

NameRenalytix plc
CIK0001811115
TickersRNLXY, RENXF
ExchangesOTC, OTC
Entity typeoperating
Category<br>Emerging growth company
SIC8071 Services-Medical Laboratories
EIN000000000
LEI—
Fiscal year end0630
State of incorporationX0 United Kingdom
Phone44 29 2071 0570
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Renalytix AI plc (2020-05-15T00:00:00.000Z → 2021-06-25T00:00:00.000Z)
Business address
FINSGATE
5-7 CRANWOOD STREET
LONDON
United Kingdom
X0
Mailing address
FINSGATE
5-7 CRANWOOD STREET
LONDON
United Kingdom
X0

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

233 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-02-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-018599 005-93440 26665500 34 13372
2025-12-03 F-6 POS e664991_f6pos-renalytix.htm 0001193805-25-001709 333-239729 251546537 33 456987
2025-09-04 F-6 POS e664769_f6pos-renalytix.htm 0001193805-25-001256 333-239729 251292752 33 717461
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002402 333-279966 251169093 33 1930
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002400 333-278765 251169091 33 1930
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002399 333-274733 251169090 33 1930
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002398 333-271579 251169089 33 1930
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002397 333-265280 251169087 33 1930
2025-07-30 424B3 e664746_424b3-renalytix.htm 0001193805-25-001128 333-239729 251167399 33 172966
2025-07-30 15-12G FORM 15-12G 0001213900-25-069259 001-39387 251166850 34 16817
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001213900-25-068777 333-274733 251162726 33 23034
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001213900-25-068773 333-279966 251162697 33 23299
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001213900-25-068772 333-278765 251162686 33 22651
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-3 ON FORM S-3 0001213900-25-068769 333-271579 251162647 33 23194
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-3 ON FORM S-3 0001213900-25-068768 333-265280 251162634 33 24762
2025-07-25 S-8 POS REGISTRATION STATEMENT 0001213900-25-067774 333-274732 251152015 33 19608
2025-07-25 S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-25-067773 333-248741 251152014 33 18518
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001610520-25-000062 005-93440 25896170 34 7143
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001610520-25-000061 005-93440 25895436 34 7115
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001610520-25-000008 005-93440 25603949 34 7196
2025-01-16 8-K CURRENT REPORT 7.01 0001213900-25-004220 001-39387 25535991 34 193938 1 1
2024-12-20 8-K CURRENT REPORT 5.07,7.01,9.01 0001213900-24-111219 001-39387 241568406 34 273375 1 1
2024-11-25 DEF 14A PROXY STATEMENT 0001213900-24-102087 001-39387 241495648 34 3371737
2024-11-19 8-K/A AMENDMENT NO. 1 TO FORM 8-K 1.01,2.03,9.01 0001213900-24-100211 001-39387 241477048 34 221756 1 1
2024-11-19 10-Q 10-Q 0000950170-24-128687 001-39387 241476735 34 7981328 1 1
2024-11-14 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-24-098540 001-39387 241463942 34 16524
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118635 005-93440 241459300 34 59604
2024-11-12 PRE 14A PROXY STATEMENT 0001213900-24-096777 001-39387 241449431 34 3175000
2024-11-07 SC 13D/A SCHEDULE 13D/A 0001104659-24-115272 005-93440 241435219 34 53108
2024-11-06 8-K CURRENT REPORT 5.02,5.07,7.01,9.01 0001213900-24-095002 001-39387 241431347 34 250511 1 1
2024-11-05 4 4 0000950170-24-121609 12711
2024-11-05 SC 13D/A SCHEDULE 13D, AMENDMENT NO. 2 0001341004-24-000185 005-93440 241428383 34 99719
2024-10-11 DEF 14A DEF 14A 0001193125-24-236760 001-39387 241367950 34 400507
2024-10-07 25 25 0001193125-24-233820 001-39387 241358161 34 11146
2024-10-02 SC 13D/A SC 13D/A 0001104659-24-105554 005-93440 241349554 34 53920
2024-10-01 PRE 14A PRE 14A 0001193125-24-230327 001-39387 241344364 34 295604
2024-10-01 8-K 8-K 1.01,2.01,2.02,2.03,3.01,3.02,8.01,9.01 0001193125-24-230319 001-39387 241344337 34 1267242 1 1
2024-09-30 10-K 10-K 0000950170-24-110315 001-39387 241339136 34 11379691 1 1
2024-08-27 8-K 8-K 3.01,7.01,9.01 0000950170-24-100790 001-39387 241243172 34 299329 1 1
2024-07-15 8-K 8-K 3.02,7.01,9.01 0000950170-24-083385 001-39387 241115858 34 275902 1 1
2024-06-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-28 16:00:00 9999999995-24-002016 333-279966 241087729 33 1862
2024-06-28 424B3 424B3 0001193125-24-172301 333-279966 241086095 33 457999
2024-06-26 CORRESP filename1.htm 0000950170-24-077922 21595
2024-06-26 S-3/A S-3/A 0001193125-24-168194 333-279966 241070417 33 517751
2024-06-25 8-K/A 8-K/A 4.01,9.01 0000950170-24-077428 001-39387 241069972 34 208207 1 1
2024-06-24 8-K 8-K 3.01 0000950170-24-076884 001-39387 241065304 34 200556 1 1
2024-06-24 8-K 8-K 4.01,9.01 0000950170-24-076873 001-39387 241065243 34 206792 1 1
2024-06-17 8-K 8-K 7.01,9.01 0000950170-24-074280 001-39387 241048679 34 251449 1 1
2024-06-14 S-3/A S-3/A 0001193125-24-161244 333-279966 241043308 33 510121
2024-06-13 4 xslF345X05/form4-06132024_040602.xml 0001415889-24-016663 5858
2024-06-12 8-K 8-K 5.02,9.01 0000950170-24-072531 001-39387 241039100 34 308586 1 1
2024-06-11 UPLOAD filename1.pdf 0000000000-24-006698 333-279966 40418
2024-06-05 S-3 S-3 0001193125-24-155159 333-279966 241022415 33 599883
2024-06-05 3 xslF345X02/form3-06052024_080655.xml 0001415889-24-015558 9296
2024-05-28 8-K 8-K 5.02,7.01,9.01 0000950170-24-064882 001-39387 24986262 34 251840 1 1
2024-05-15 424B5 424B5 0001193125-24-139032 333-274733 24947907 33 627769
2024-05-15 8-K 8-K 1.01,9.01 0000950170-24-060084 001-39387 24947596 34 811692 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060033 001-39387 24947140 34 9087999 1 1
2024-05-15 8-K 8-K 2.02,9.01 0000950170-24-060026 001-39387 24947085 34 616388 1 1
2024-05-08 424B3 424B3 0001193125-24-133371 333-278765 24923628 33 484484
2024-04-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-29 16:00:00 9999999995-24-001189 333-278765 24893784 33 1861
2024-04-26 4 xslF345X05/form4.xml 0000950172-24-000236 12132
2024-04-26 SC 13D/A SCHEDULE 13D/A - AMENDMENT NO. 1 0001341004-24-000089 005-93440 24883384 34 106448
2024-04-26 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-24-048658 001-39387 24878738 34 272152 1 1
2024-04-25 CORRESP filename1.htm 0000950170-24-048258 21946
2024-04-25 UPLOAD filename1.pdf 0000000000-24-004610 333-278765 40468
2024-04-23 8-K 8-K 1.01,5.02,5.07,9.01 0000950170-24-047020 001-39387 24865577 34 339900 1 1
2024-04-17 S-3 S-3 0001193125-24-099188 333-278765 24851712 33 638705
2024-04-10 8-K 8-K 3.02,7.01,9.01 0000950170-24-043336 001-39387 24835726 34 253366 1 1
2024-04-09 8-K 8-K 1.01,9.01 0000950170-24-043030 001-39387 24833301 34 601323 1 1
2024-04-09 424B5 424B5 0001193125-24-090873 333-274733 24833112 33 690827
2024-04-08 8-K 8-K 7.01,9.01 0000950170-24-042424 001-39387 24828183 34 253063 1 1
2024-04-04 SC 13G SC 13G 0001104659-24-043459 005-93440 24821920 34 68523
2024-03-29 DEF 14A DEF 14A 0001193125-24-082155 001-39387 24804705 34 297350
2024-03-29 8-K 8-K 1.01,9.01 0000950170-24-038614 001-39387 24804061 34 1723723 1 1
2024-03-21 SC 13D/A SC 13D/A 0001104659-24-037203 005-93440 24771049 34 52495
2024-03-19 PRE 14A PRE 14A 0001193125-24-071330 001-39387 24763567 34 296316
2024-03-14 8-K 8-K 7.01,9.01 0000950170-24-031141 001-39387 24747912 34 242541 1 1
2024-03-13 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-24-030496 001-39387 24744534 34 1376633 1 1
2024-03-04 8-K 8-K 7.01,9.01 0000950170-24-024338 001-39387 24712796 34 257621 1 1
2024-02-29 8-K 8-K 7.01 0000950170-24-022604 001-39387 24698613 34 203378 1 1
2024-02-15 8-K 8-K 2.02,9.01 0000950170-24-015596 001-39387 24642008 34 878562 1 1
2024-02-14 10-Q 10-Q 0000950170-24-015276 001-39387 24639115 34 9108450 1 1
2024-02-09 8-K 8-K 7.01,9.01 0000950170-24-013048 001-39387 24611116 34 264237 1 1
2024-01-17 8-K 8-K 7.01,9.01 0000950170-24-004821 001-39387 24536700 34 267560 1 1
2024-01-10 8-K 8-K 7.01,9.01 0000950170-24-003514 001-39387 24524859 34 280718 1 1
2023-12-29 8-K 8-K 3.01 0001193125-23-305948 001-39387 231527615 34 200759 1 1
2023-12-18 8-K 8-K 3.02,7.01,9.01 0000950170-23-071065 001-39387 231493635 34 266764 1 1
2023-12-18 8-K 8-K 5.07 0000950170-23-070946 001-39387 231492260 34 227719 1 1
2023-12-08 DEFA14A DEFA14A 0001193125-23-291784 001-39387 231476205 34 13028
2023-12-08 8-K 8-K 5.02,9.01 0000950170-23-069033 001-39387 231475294 34 196170 1 1
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056478 5714
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056477 5719
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056476 5761
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056475 5764
2023-11-22 4 FORM 4 SUBMISSION 0001209191-23-056474 5894
2023-11-17 ARS ARS 0001193125-23-279769 001-39387 231418503 34 3814321
2023-11-14 10-Q 10-Q 0000950170-23-063363 001-39387 231401657 34 8616186 1 1
2023-11-14 8-K 8-K 2.02,9.01 0000950170-23-063352 001-39387 231401584 34 701511 1 1
2023-11-13 DEFR14A DEFR14A 0001193125-23-276201 001-39387 231400054 34 2238939
2023-11-13 DEF 14A DEF 14A 0001193125-23-275494 001-39387 231395776 34 2234775
2023-11-03 PRE 14A PRE 14A 0001193125-23-270366 001-39387 231376276 34 2235151
2023-10-31 8-K 8-K 7.01,9.01 0000950170-23-056841 001-39387 231364468 34 248672 1 1
2023-10-24 8-K 8-K 5.02,9.01 0000950170-23-054705 001-39387 231341196 34 198437 1 1
2023-10-17 8-K 8-K 7.01,9.01 0000950170-23-053654 001-39387 231328467 34 251697 1 1
2023-10-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-10-06 17:00:00 9999999995-23-002955 333-274733 231315327 33 1790
2023-10-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-244702,2023-10-06 9999999995-23-002951 333-271579 231315323 33 1803
2023-10-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-244700,2023-10-06 9999999995-23-002950 333-265280 231315322 33 1803
2023-10-06 10-K/A 10-K/A 0000950170-23-052245 001-39387 231312453 34 3325151 1 1
2023-10-05 CORRESP filename1.htm 0001193125-23-251675 16937
2023-10-03 8-K 8-K 7.01,9.01 0000950170-23-051276 001-39387 231301541 34 212527 1 1
2023-10-03 RW WD RW WD 0001193125-23-249311 333-274733 231301471 NE 11595
2023-10-02 CORRESP filename1.htm 0001193125-23-249198 10643
2023-10-02 RW RW 0001193125-23-249007 333-274733 231299538 NE 10718
2023-10-02 UPLOAD filename1.pdf 0000000000-23-010865 40400
2023-09-29 CORRESP filename1.htm 0001193125-23-246933 11416
2023-09-28 8-K 8-K 2.02,9.01 0000950170-23-050236 001-39387 231286154 34 1476637 1 1
2023-09-28 S-3 S-3 0001193125-23-244704 333-274733 231286118 33 1118036
2023-09-28 POS AM POS AM 0001193125-23-244702 333-271579 231286117 33 504383
2023-09-28 POS AM POS AM 0001193125-23-244700 333-265280 231286116 33 494419
2023-09-28 S-8 S-8 0001193125-23-244692 333-274732 231286111 33 144999
2023-09-28 10-K 10-K 0000950170-23-050231 001-39387 231286093 34 15552331 1 1
2023-09-22 8-K 8-K 7.01,9.01 0000950170-23-049314 001-39387 231270233 34 210701 1 1
2023-09-12 3 FORM 3 SUBMISSION 0001209191-23-049092 6723
2023-09-08 8-K 8-K 5.02,7.01,9.01 0000950170-23-047260 001-39387 231245303 34 318352 1 1
2023-08-21 8-K 8-K 7.01 0000950170-23-043554 001-39387 231187305 34 217660 1 1
2023-07-17 8-K 8-K 7.01,9.01 0000950170-23-033233 001-39387 231092346 34 266392 1 1
2023-07-11 4 FORM 4 SUBMISSION 0001209191-23-042021 5777
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041802 5784
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041800 5754
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041799 5801
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041797 5775
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041796 5781
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041795 5808
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040583 7522
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040581 9003
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040580 9204
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040578 10410
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040576 11559
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040574 8271
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040573 6647
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040572 8188
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040571 8854
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040570 8061
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040569 6615
2023-07-03 8-K 8-K 5.02,7.01,9.01 0000950170-23-031366 001-39387 231064810 34 269485 1 1
2023-07-03 3 FORM 3 SUBMISSION 0001209191-23-040414 11982
2023-07-03 8-K 8-K 7.01 0000950170-23-031264 001-39387 231063627 34 209751 1 1
2023-06-30 6-K 6-K 0000950170-23-030904 001-39387 231059390 34 224614 1 1
2023-06-09 6-K 6-K 0000950170-23-027251 001-39387 231005234 34 28649
2023-06-09 6-K 6-K 0000950170-23-027126 001-39387 231003847 34 9105177 1 1
2023-05-22 6-K 6-K 0000950170-23-023317 001-39387 23942403 34 34502
2023-05-11 6-K 6-K 0000950170-23-021365 001-39387 23912057 34 288232
2023-05-11 6-K 6-K 0000950170-23-020885 001-39387 23909210 34 93786
2023-05-10 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2023-05-10 16:00:00 9999999995-23-001372 333-271579 23908614 33 1789
2023-05-10 424B3 424B3 0001193125-23-140734 333-271579 23906534 33 560044
2023-05-08 CORRESP filename1.htm 0001193125-23-138231 21964
2023-05-05 UPLOAD filename1.pdf 0000000000-23-004719 40407
2023-05-02 F-3 F-3 0001193125-23-132566 333-271579 23879812 33 718740
2023-03-30 6-K 6-K 0000950170-23-010747 001-39387 23777122 34 8760384 1 1
2023-03-27 6-K 6-K 0000950170-23-009860 001-39387 23761473 34 38023
2023-03-21 6-K 6-K 0000950170-23-008841 001-39387 23747878 34 34497
2023-03-10 6-K 6-K 0000950170-23-007329 001-39387 23724408 34 30381
2023-02-17 SC 13D SC 13D 0001104659-23-023247 005-93440 23642137 34 131367
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020335 005-93440 23621846 34 53439
2023-02-10 SC 13D SCHEDULE 13D 0001341004-23-000051 005-93440 23613128 34 264953
2023-02-08 6-K 6-K 0000950170-23-002193 001-39387 23600028 34 1433104
2022-12-20 6-K 6-K 0000950170-22-026818 001-39387 221474496 34 58390
2022-11-30 6-K 6-K 0000950170-22-025833 001-39387 221434316 34 7631148 1 1
2022-11-29 6-K 6-K 0000950170-22-025758 001-39387 221428284 34 134081
2022-11-22 6-K 6-K 0000950170-22-025617 001-39387 221411419 34 3479474
2022-10-31 20-F 20-F 0000950170-22-020618 001-39387 221346488 34 22130216 1 1
2022-10-25 6-K 6-K 0000950170-22-019966 001-39387 221327658 34 115038
2022-09-21 6-K 6-K 0000950170-22-018706 001-39387 221255233 34 103500
2022-08-17 6-K 6-K 0000950170-22-017530 001-39387 221172074 34 35542
2022-08-02 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-208835,2022-08-02 9999999995-22-002225 333-265280 221130771 33 1803
2022-08-01 POS AM POS AM 0001193125-22-208835 333-265280 221125559 33 584761
2022-08-01 20-F/A 20-F/A 0001193125-22-208827 001-39387 221125530 34 6973334 1 1
2022-06-30 6-K 6-K 0000950170-22-012342 001-39387 221056484 34 7281084 1 1
2022-06-27 6-K 6-K 0000950170-22-012196 001-39387 221044984 34 89563
2022-06-06 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2022-06-06 16:00:00 9999999995-22-001704 333-265280 22999739 33 1789
2022-06-06 424B3 424B3 0001193125-22-168374 333-265280 22998461 33 623847
2022-06-02 CORRESP filename1.htm 0001193125-22-165916 13229
2022-06-01 UPLOAD filename1.pdf 0000000000-22-005930 40231
2022-05-27 F-3 F-3 0001193125-22-162328 333-265280 22977388 33 924168
2022-05-27 SC 13G/A SC 13G/A 0001140361-22-021007 005-93440 22976852 34 149632
2022-05-27 SC 13G SC 13G 0001140361-22-020971 005-93440 22975837 34 143991
2022-04-29 6-K/A 6-K/A 0000950170-22-006745 001-39387 22877038 34 7079703 1 1
2022-04-01 6-K 6-K 0000950170-22-005284 001-39387 22798101 34 188632
2022-03-31 6-K 6-K 0000950170-22-005105 001-39387 22789077 34 1303493
2022-02-14 SC 13G/A SCHEDULE 13G/A 0001104659-22-021551 005-93440 22625118 34 61394
2022-02-11 SC 13G SC 13G 0001104659-22-020532 005-93440 22621233 34 60309
2022-02-01 UPLOAD filename1.pdf 0000000000-22-001281 39706
2022-01-27 CORRESP filename1.htm 0001193125-22-019762 15687
2022-01-27 20-F/A 20-F/A 0001193125-22-019752 001-39387 22563135 34 288793 1 1
2022-01-24 UPLOAD filename1.pdf 0000000000-22-000924 43361
2021-12-20 6-K 6-K 0001193125-21-362349 001-39387 211505284 34 17711
2021-12-07 6-K 6-K 0001193125-21-350220 001-39387 211476028 34 311340
2021-11-30 6-K 6-K 0001193125-21-343667 001-39387 211459856 34 2311039
2021-10-21 20-F 20-F 0001193125-21-303600 001-39387 211335812 34 14581672 1 1
2021-10-21 6-K 6-K 0001193125-21-303481 001-39387 211335609 34 421802
2021-08-30 6-K 6-K 0001193125-21-260592 001-39387 211223577 34 29878
2021-07-28 6-K 6-K 0001193125-21-227462 001-39387 211123059 34 29779
2021-07-06 6-K 6-K 0001193125-21-208717 001-39387 211074095 34 24697
2021-07-06 424B3 e620768_424b3-renalytix.htm 0001193805-21-000977 333-239729 211073254 33 145589
2021-06-25 6-K 6-K 0001193125-21-198911 001-39387 211044052 34 19236
2021-06-15 6-K 6-K 0001193125-21-190508 001-39387 211016788 34 407022
2021-06-10 6-K 6-K 0001193125-21-187248 001-39387 211006821 34 33532
2021-03-02 6-K 6-K 0001193125-21-064420 001-39387 21701215 34 383248
2020-12-07 6-K 6-K 0001193125-20-311871 001-39387 201373464 34 22944
2020-11-25 6-K 6-K 0001193125-20-303077 001-39387 201346862 34 272892
2020-11-10 20-F/A 20-F/A 0001193125-20-289263 001-39387 201298961 34 3769127 1
2020-10-28 20-F 20-F 0001193125-20-278751 001-39387 201265580 34 4147473
2020-10-27 6-K 6-K 0001193125-20-277467 001-39387 201261973 34 633789
2020-09-21 6-K 6-K 0001193125-20-250165 001-39387 201186406 34 23743
2020-09-11 S-8 S-8 0001193125-20-244104 333-248741 201170994 33 152923
2020-07-17 424B4 424B4 0001193125-20-194811 333-239414 201034386 33 4994624
2020-07-17 CERT 8A_Cert_RNLX.pdf 0001354457-20-000341 001-39387 201032896 34 139694
2020-07-17 FWP FWP 0001193125-20-194303 333-239414 201032715 34 25247
2020-07-16 EFFECT xslEFFECTX01/primary_doc.xml F-6,,2020-07-16 16:00:00 9999999995-20-001834 333-239729 201032696 33 1719
2020-07-16 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2020-07-16 16:00:00 9999999995-20-001827 333-239414 201032677 33 1719
2020-07-14 CORRESP filename1.htm 0001193125-20-192609 12215
2020-07-14 CORRESP filename1.htm 0001193125-20-192604 13241
2020-07-13 F-6/A e619772_f6a-renalytix.htm 0001193805-20-000834 333-239729 201025874 33 527408
2020-07-13 8-A12B 8-A12B 0001193125-20-191900 001-39387 201025441 34 17272
2020-07-13 F-1/A F-1/A 0001193125-20-191467 333-239414 201024277 33 5837787
2020-07-07 F-6 e619745_f6-renalytix.htm 0001193805-20-000803 333-239729 201016397 33 553410
2020-07-06 CORRESP filename1.htm 0001193125-20-188050 21366
2020-07-01 UPLOAD filename1.pdf 0000000000-20-005923 43392
2020-06-24 CORRESP filename1.htm 0001193125-20-177776 49529
2020-06-24 F-1 F-1 0001193125-20-177760 333-239414 20986336 33 7429035
2020-06-11 UPLOAD filename1.pdf 0000000000-20-005205 50984
2020-05-15 DRS filename1.htm 0000950123-20-005421 377-03177 20886810 33 4607664

Latest XBRL company facts

One latest value per concept from companyfacts (261 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 331.21M 2024-11-07 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
dei EntityPublicFloat Entity Public Float USD 24.71M 2023-12-29 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.75M 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 1.45M 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 40,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 902,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.16M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 694,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 313,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.03M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 206.71M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 254,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 254,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 50,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.91M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap Assets Assets USD 4.79M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap AssetsCurrent Assets, Current USD 2.88M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2022-07-01 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 100,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 1.60M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 900,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers Capitalized Software Development Costs for Software Sold to Customers USD 1.10M 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap Cash Cash USD 4.70M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 909,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -23.80M 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 41.33M 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 909,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.77M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 62,000 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share GBP/shares 0.003 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 173.84M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 165.93M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 165.93M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CommonStockValue Common Stock, Value, Issued USD 515,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -54.47M 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 5.31M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -45.24M 2021-07-01 2022-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 4.10M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 21.20M 2022-04-30 6-K 2022-06-30 0000950170-22-012342
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 4.14M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CostOfRevenue Cost of Revenue USD 422,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2019-07-01 2020-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap DebtAndEquitySecuritiesRealizedGainLoss Debt and Equity Securities, Realized Gain (Loss) USD 18,000 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.055 2022-04-01 2022-04-30 6-K 2022-06-30 0000950170-22-012342
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 7.792 2023-04-07 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 8.20M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.05 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.055 2022-04-05 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 300,000 2022-10-01 2022-10-31 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 1.63M 2019-07-01 2020-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 46,000 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 1.40M 2022-04-07 2024 Q3 10-Q 2024-05-15 0000950170-24-060033
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 82,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 504,000 2022-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap DeferredRevenue Deferred Revenue USD 0 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 0 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction USD 14,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.91M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 82,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 45.96M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 97,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.35M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.76M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 46,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 0 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 384,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 55.44M 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 66,000 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 0 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap Depreciation Depreciation USD 10,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 60,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DividendsCash Dividends, Cash USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap DividendsReceivable Dividends Receivable USD 6,000 2021-12-31 6-K/A 2022-04-29 0000950170-22-006745
us-gaap DueFromAffiliateCurrent Due from Affiliate, Current USD 0 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap DueToAffiliateCurrent Due to Affiliate, Current USD 0 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap DueToAffiliateNoncurrent Due to Affiliate, Noncurrent USD 1.54M 2020-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.04 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.49 2020-07-01 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.04 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.284 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.009 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.039 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.007 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.044 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -2.84M 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 42,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 259,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap EquityMethodInvestmentsFairValueDisclosure Equity Method Investments, Fair Value Disclosure USD 0 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD -42,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 8.24M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 732,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 179,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 141,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 33,000 2022-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 133,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 133,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 133,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 150,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.53M 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 869,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.796 2020-07-31 2020 FY 20-F/A 2020-11-10 0001193125-20-289263
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 37,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 18,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap GainLossOnSalesOfLoansNet Gain (Loss) on Sales of Loans, Net USD 255,000 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 255,000 2020-07-01 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.27M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap GrossProfit Gross Profit USD 100,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 723,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -20.95M 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -4.73M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -12.50M 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -33.45M 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.42M 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 1.39M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 1.55M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 154,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.31M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncreaseDecreaseInDueFromAffiliatesCurrent Increase (Decrease) in Due from Affiliates, Current USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -17,000 2020-07-01 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap IncreaseDecreaseInDueToAffiliates Increase (Decrease) in Due to Affiliates USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap IncreaseDecreaseInNotesReceivableRelatedParties Increase (Decrease) in Notes Receivable, Related Parties USD -167,000 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 327,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 869,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 21,000 2018-07-01 2019-06-30 2021 FY 20-F 2021-10-21 0001193125-21-303600
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 776,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 0 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure USD 2.70M 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValue Investments in and Advances to Affiliates, at Fair Value USD 1.64M 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 700,000 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap LeaseCost Lease, Cost USD 114,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 11,600 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 11,600 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2022-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 0 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 33,000 2022-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 100 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap Liabilities Liabilities USD 16.11M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 4.79M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.01M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap LoansAndLeasesReceivableRelatedParties Loans and Leases Receivable, Related Parties USD 75,000 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 23,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.84M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -4.73M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -45.28M 2021-07-01 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 2.30M 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap NontradeReceivables Nontrade Receivables USD 200,000 2021-03-31 6-K 2022-06-30 0000950170-22-012342
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 0 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2020-06-30 2020 FY 20-F/A 2020-11-10 0001193125-20-289263
us-gaap NotesPayableToBankNoncurrent Notes Payable to Bank, Noncurrent USD 135,000 2020-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 75,000 2023-03-31 6-K 2023-06-09 0000950170-23-027126
us-gaap NotesReceivableRelatedPartiesNoncurrent Notes Receivable, Related Parties, Noncurrent USD 83,000 2020-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap OperatingExpenses Operating Expenses USD 4.19M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.09M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 92,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 11,500 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 11,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 360,000 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 162,000 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 28,000 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 83,000 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 45,000 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 153,000 2022-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OriginationOfNotesReceivableFromRelatedParties Origination of Notes Receivable from Related Parties USD 83,000 2019-07-01 2020-06-30 2020 FY 20-F/A 2020-11-10 0001193125-20-289263
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 163,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OtherAssets Other Assets USD 937,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -461,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -454,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -12.64M 2022-07-01 2022-09-30 6-K 2022-11-30 0000950170-22-025833
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 53,000 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 100,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2023-11-14 0000950170-23-063363
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -5,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 8.80M 2022-03-01 2022-03-31 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 11.02M 2018-07-01 2019-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap PaymentsToAcquireOtherPropertyPlantAndEquipment Payments to Acquire Other Property, Plant, and Equipment USD 4,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 21.26M 2019-07-01 2020-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.07M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 13.53M 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 255,000 2019-07-01 2020-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 20.30M 2023-02-09 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 14.90M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 18.00M 2022-04-07 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 633,000 2018-07-01 2019-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 23,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 1.00M 2020-07-01 2021-06-30 2022 FY 20-F 2022-10-31 0000950170-22-020618
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 515,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 202,000 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD -25,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 1.07M 2018-07-01 2019-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 921,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 35.29M 2018-07-01 2019-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -216.51M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 100,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap Revenues Revenues USD 522,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 254,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.832 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.64M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.87 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 75,184 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 517,500 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.92M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.06 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 7.92M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 3.06 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.62 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.24 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share GBP/shares 0.09 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 120,000 2020-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap ShortTermInvestments Short-term Investments USD 0 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 95,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -11.32M 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockIssued1 Stock Issued USD 24.29M 2018-07-01 2019-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 36.55M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.59M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 93,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.03M 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-05-15 0000950170-24-060033
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 66,000 2018-03-15 2018-06-30 2020 FY 20-F/A 2020-11-10 0001193125-20-289263
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 1,000 2023-07-01 2023-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 197,000 2021-07-01 2022-06-30 2023 FY 10-K 2023-09-28 0000950170-23-050231
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 9.80M 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000950170-24-110315
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 105.70M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 71.48M 2020-07-01 2021-06-30 2021 FY 20-F/A 2022-08-01 0001193125-22-208827
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 105.70M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-19 0000950170-24-128687

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →